Press Releases

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2023. "As we reflect on the past year, our 2023 financial performance highlighted the...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Tuesday, February 13, 2024, at 5:00 p.m. Eastern Time. The company...

Due to weather conditions from a widespread winter storm (Jan. 12 – 16, 2024), DaVita centers may be closed or experiencing a delayed start. DaVita’s care teams across the region are working...

Funding to support co-created 'Start Early' program aimed at increasing degree completion rates DENVER, Dec. 19, 2023 /PRNewswire/ -- The DaVita Giving Foundation has awarded Western Governors...

Since 2007, DaVita has raised millions and impacted thousands globally through annual activity-based events DENVER, Nov. 30, 2023 /PRNewswire/ -- DaVita, a leading provider of kidney care...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2023. "We delivered another strong quarter," said Javier Rodriguez, CEO of DaVita Inc. "We...

Research includes studies designed to overcome barriers to living donation and in-home treatment among African American and Spanish-speaking Mexican American patients DENVER and PHILADELPHIA, Nov....

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 7, 2023, at 5:00 p.m. Eastern Time. The company plans...

DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like peptide 1 (GLP-1) receptor agonist indicated for type 2 diabetes,...

Kidney care provider invests in early detection and prevention to help reduce progression of chronic kidney disease in key communities it serves DENVER, Sept. 13, 2023 /PRNewswire/ -- DaVita Inc....

Collaboration includes launch of new nursing curriculum that increases access to career pathways post-graduation DENVER, Sept. 12, 2023 /PRNewswire/ -- DaVita Inc., a leading kidney care provider,...

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat hosted...

For the most up-to-date information on how Hurricane Idalia has affected your DaVita center, please call DaVita Guest Services at 1-800-400-8331. Hurricane Idalia is anticipated to make landfall...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2023. "Over the first half of the year, DaVita has been focused on innovation in our clinical...

DaVita Inc. today announced that its Board of Directors appointed a new independent director, Wendy Schoppert, to join the Board, effective as of July 14, 2023. "We're pleased to welcome Wendy to...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Thursday, August 3rd, 2023, at 5:00 p.m. Eastern Time. The company...

Recognizes nurses who further DaVita's mission to be the provider and employer of choice. DENVER, May 10, 2023 /PRNewswire/ -- DaVita Inc. today announced that 56 of its nephrology nurses were...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2023. "In the first quarter, we performed well on our key metrics and our results benefited from...

DaVita Inc. today published its 2022 Community Care Report, reinforcing its long-standing commitment to corporate citizenship and highlighting meaningful progress made toward meeting the 2025...

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the BofA Securities Healthcare Conference 2023 on...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 8, 2023, at 5:00 p.m. Eastern Time. The company plans to...

Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA) today announced the launch of Mozarc Medical—an independent new company committed to reshaping kidney health and driving patient-centered...

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Barclays 2023 Global Healthcare Conference on...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2022. "We continue to have excitement and conviction in our long-term capabilities and...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter and full year results on Wednesday, February 22, 2023, at 5:00 p.m. Eastern Time....